| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |